Scientech Research’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-11,032
Closed -$794K – 443
2026
Q1
$794K Buy
+11,032
New +$628K 0.66% 24
2024
Q1
– Sell
-2,015
Closed -$17.1K – 521
2023
Q4
$17.1K Buy
+2,015
New +$15.3K 0.02% 299

Other funds holding NKTR

Scientech Research's NKTR Position: Q2 2026 in Review

Scientech Research sold out of Nektar Therapeutics (NKTR) in Q2 2026, closing a stake of 11,032 shares — an estimated $794K sold.

Scientech Research first reported a position in NKTR in Q4 2023 and held it in 2 quarters. The position peaked at $794K in Q1 2026. 242 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Scientech Research reported no remaining Nektar Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research sold 11,032 Nektar Therapeutics shares in Q2 2026, an estimated $794K.
  • Scientech Research first reported a position in Nektar Therapeutics in Q4 2023 and held it in 2 quarters.
  • Scientech Research's Nektar Therapeutics position peaked at $794K in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.